Blood filter aims to suck cancer cells out of patients with advanced tumors
NCT ID NCT06655142
First seen Apr 20, 2026 · Last updated May 13, 2026 · Updated 6 times
Summary
This study tests a device called ONCObind that filters blood to remove circulating tumor cells in patients with advanced pancreatic or colorectal cancer that has spread and is no longer responding to standard treatments. About 120 adults will receive the filter procedure multiple times, and researchers will monitor safety, tumor cell levels, survival, and quality of life. The goal is to see if this approach can help control the disease when other options have failed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CARCINOMA (MCRC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.